40
Participants
Start Date
November 30, 2007
Primary Completion Date
February 29, 2008
Study Completion Date
April 30, 2009
Levosimendan
Intravenous administration of Levosimendan 0,2 µg•kg-1•min-1 for 24 hrs followed by the addition of 35 ppm of inhaled nitric oxide
dobutamine
Intravenous administration of dobutamine 5 µg•kg-1•min-1 for 36 hrs. At the end of the first 24 hrs drug infusion, inhaled nitric oxide at the concentration of 35 ppm will be added for further 12 hrs.
"Departement of Anesthesiology and Intensive Care of the University of Rome La Sapienza Viale del Policlinico 155", Rome
University of Roma La Sapienza
OTHER